Detalhe da pesquisa
1.
Deep Learning Classification of Usual Interstitial Pneumonia Predicts Outcomes.
Am J Respir Crit Care Med
; 209(9): 1121-1131, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38207093
2.
Pulmonary Fibrosis Stakeholder Summit: A Joint NHLBI, Three Lakes Foundation, and Pulmonary Fibrosis Foundation Workshop Report.
Am J Respir Crit Care Med
; 209(4): 362-373, 2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38113442
3.
Meaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials: Emphasis on 'Feels, Functions, Survives'. Report of a Collaborative Discussion in a Symposium with Direct Engagement from Representatives of Patients, Investigators, the National Institutes of Health, a Patient Advocacy Organization, and a Regulatory Agency.
Am J Respir Crit Care Med
; 209(6): 647-669, 2024 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38174955
4.
Effects of nintedanib on symptoms in patients with progressive pulmonary fibrosis.
Eur Respir J
; 63(2)2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38135442
5.
Proteomic Biomarkers of Survival in Idiopathic Pulmonary Fibrosis.
Am J Respir Crit Care Med
; 2023 Oct 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37847691
6.
Nintedanib in children and adolescents with fibrosing interstitial lung diseases.
Eur Respir J
; 61(2)2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36041751
7.
Progressive pulmonary fibrosis: an expert group consensus statement.
Eur Respir J
; 61(3)2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36517177
8.
Expert consensus on the management of systemic sclerosis-associated interstitial lung disease.
Respir Res
; 24(1): 6, 2023 Jan 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36624431
9.
B7H3 expression and significance in idiopathic pulmonary fibrosis.
J Pathol
; 256(3): 310-320, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34825713
10.
Phase 2B Study of Inhaled RVT-1601 for Chronic Cough in Idiopathic Pulmonary Fibrosis: A Multicenter, Randomized, Placebo-controlled Study (SCENIC Trial).
Am J Respir Crit Care Med
; 205(9): 1084-1092, 2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35050837
11.
Syndrome of Combined Pulmonary Fibrosis and Emphysema: An Official ATS/ERS/JRS/ALAT Research Statement.
Am J Respir Crit Care Med
; 206(4): e7-e41, 2022 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35969190
12.
Integrating Clinical Probability into the Diagnostic Approach to Idiopathic Pulmonary Fibrosis: An International Working Group Perspective.
Am J Respir Crit Care Med
; 206(3): 247-259, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35353660
13.
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases.
N Engl J Med
; 381(18): 1718-1727, 2019 10 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-31566307
14.
Nintedanib in progressive interstitial lung diseases: data from the whole INBUILD trial.
Eur Respir J
; 59(3)2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34475231
15.
Effects of nintedanib by inclusion criteria for progression of interstitial lung disease.
Eur Respir J
; 59(2)2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34210788
16.
Predictors of mortality in subjects with progressive fibrosing interstitial lung diseases.
Respirology
; 27(4): 294-300, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35224814
17.
Association of Circulating Proteins with Death or Lung Transplant in Patients with Idiopathic Pulmonary Fibrosis in the IPF-PRO Registry Cohort.
Lung
; 200(1): 11-18, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35066606
18.
Design and rationale for the prospective treatment efficacy in IPF using genotype for NAC selection (PRECISIONS) clinical trial.
BMC Pulm Med
; 22(1): 475, 2022 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36514019
19.
The justification for the progressive fibrotic phenotype.
Curr Opin Pulm Med
; 27(5): 363-367, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34231534
20.
Effect of Antimicrobial Therapy on Respiratory Hospitalization or Death in Adults With Idiopathic Pulmonary Fibrosis: The CleanUP-IPF Randomized Clinical Trial.
JAMA
; 325(18): 1841-1851, 2021 05 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33974018